CClinicalTrials.gg
RecruitingNCT06671184Updated May 7, 2026

Nomogram for Predicting Difficult Transoral and Submental Thyroidectomy

An observational study in Differentiated Thyroid Cancer, sponsored by Shanghai 6th People's Hospital. Recruiting at 1 site in China. Per ClinicalTrials.gov, last updated 2026-05-07.

Sponsored by Shanghai 6th People's Hospital · Observational

From the registry’s dates

  • Started Jan 2021; still recruiting 5 years 9 months later.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
500
Sex
All
01

Study summary

No prior studies have stratified the difficulty of transoral and submental thyroidectomy (TOaST). The investigators aimed to investigate preoperative factors as indicators of difficult TOaSTs and to develop a predictive model accordingly.

Read the detailed description

Thyroid cancer is the most common endocrine malignancy, with a female predominance. Thyroidectomy is the main treatment for thyroid cancer, and considering the good prognosis of thyroid cancer, endoscopic thyroid surgery, which avoids neck incision, is being widely used in the clinic in order to improve the life treatment of patients. Among them, endoscopic thyroidectomy with transoral approach has a shorter learning curve because of the short surgical path. However, due to the complex structure of the neck, small space, and rich blood supply of the thyroid gland, surrounded by parathyroid glands and important nerves, endoscopic thyroid is difficult and has a long learning curve. In addition, a series of complications such as haemorrhage, hypoparathyroidism and laryngeal reentrant nerve injury can seriously affect the quality of patient survival. Difficult thyroidectomy is usually characterized by a long operative time, high intraoperative bleeding and a high incidence of postoperative complications. According to the literature, in open thyroid surgery, the degree of difficulty is associated with factors such as goiter, inflammation, and hyperthyroidism. However, the degree of difficulty of thyroidectomy due to various factors varies and is difficult to predict. Surgical difficulty is closely related to the outcome and safety of thyroidectomy, which is an urgent concern for surgeons. And there is no study on the degree of difficulty of transoral and submental endoscopic thyroidectomy, therefore, there is an urgent need for an effective and objective method to determine the preoperative factors affecting the degree of surgical difficulty and to establish a model for validation, so that it can be subsequently replicated in other hospitals.

02

Conditions studied

  • Differentiated Thyroid Cancer

Keywords

  • Differentiated thyroid cancer
  • Transoral and submental thyroidectomy
  • Surgical difficulty
03

In context

Lead sponsor

Shanghai 6th People's Hospital is the lead sponsor of 69 studies on the registry; 40 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients with FNA proven differentiated thyroid cancer, were willing to undergo total thyroidectomy and central lymph node dissection via transoral and submental approach. Patients were well informed about the transoral and submental approach and were aware of the potential benefits and risks. Patient consented for us to use perioperative data.

Inclusion criteria

  • Clinical diagnosis of differentiated thyroid cancer with a maximum diameter not exceeding 4 cm
  • Absence of suspicious lateral lymph nodes or distant metastases
  • Participants with high cosmetic expectations
  • Participants who underwent total thyroidectomy and central lymph node dissection.

Exclusion criteria

Exclusion Criteria:

  • Participants with fusion or fixation of lymph nodes in the neck
  • Participants with history of neck surgery or radiation
  • Participants with vocal fold fixation by preoperative fibrolaryngoscope
  • Participants with preoperative examination suggestive of extrathyroidal invasion
  • Participants with a significantly restricted neck
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
500 participants (estimated)
Patient registry
No

Groups and cohorts

  • Difficult transoral and submental thyroidectomy

    (1) operative time more than 75% of the overall study cases (2) severe intraoperative vascular or recurrent laryngeal nerve injury

    Other: Observations on clinicopathological factors influencing the difficulty of surgery

  • Normal transoral and submental thyroidectomy

    the remaining of the entire study cases excluding the difficult cases

    Other: Observations on clinicopathological factors influencing the difficulty of surgery

Interventions

  • OtherObservations on clinicopathological factors influencing the difficulty of surgery

    Age, body mass index, gender, thyroid function parameters, lesion size, lesion location, ultrasound data

06

What researchers measure

Primary outcomes

  1. Number of participants with recurrent laryngeal nerve injury

    impaired vocal cord mobility confirmed by postoperative laryngoscopy

    Time frame: through study completion, an average of 1 year

  2. Number of participants with hypoparathyroidism

    a postoperative parathyroid hormone level of less than 10 pg/ml

    Time frame: through study completion, an average of 1 year

  3. Number of participants with mental nerve injury

    a postoperative numbness in the lower lip and submental area

    Time frame: through study completion, an average of 1 year

  4. operative time

    operative time was defined as the duration from incision to closure, and was collected from anesthesia record sheet

    Time frame: through study completion, an average of 1 year

Secondary outcomes

  1. hospitalization

    days of hospitalization

    Time frame: through study completion, an average of 1 year

  2. degree of pain

    pain intensity was assessed using a standard visual analogue score, with a score of 0 to 10 corresponding to no pain to the most severe pain

    Time frame: approximately 4 hours after surgery and on postoperative day 1

07

Study locations

1 of 1 sites recruiting
  • Shanghai Sixth People's Hospital
    Shanghai, Shanghai Municipality 200233, China
    Recruiting
08

References and documents

Publications

  • Zhan L, Xuan M, Ding H, Liang J, Zhao Q, Chen L, Yang Z, Cheng X, Kuang J, Yan J, Cai W, Qiu W. Learning curve of trans-areola single-site endoscopic thyroidectomy in a high-volume center: A CUSUM-based assessment. Cancer Med. 2023 Aug;12(16):16846-16858. doi: 10.1002/cam4.6307. Epub 2023 Jul 3. PubMed 37395126 ↗
  • Liang J, Zhan L, Xuan M, Zhao Q, Chen L, Yan J, Kuang J, Tan J, Qiu W. Thyroidectomy for thyroid cancer via transareola single-site endoscopic approach: results of a case-match study with large-scale population. Surg Endosc. 2022 Feb;36(2):1394-1406. doi: 10.1007/s00464-021-08424-y. Epub 2021 Mar 29. PubMed 33782758 ↗

Individual participant data

Plan to share: Undecided — Data are available on request due to privacy or other restrictions. The data that support the findings of this study are available on request from Ling Zhan. The data are not publicly available due to them containing information that could compromise research participant privacy.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 7, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06671184
Lead sponsor
Shanghai 6th People's Hospital
Responsible party
Ling Zhan (Doctor, Shanghai 6th People's Hospital) — Principal investigator
First posted
Nov 4, 2024
Start date
Jan 1, 2021
Primary completion
Dec 31, 2027 (estimated)
Completion
Dec 31, 2027 (estimated)
Last update
May 7, 2026

Study contacts

Ling Zhan, Doctor
Contact
rebecca0428zhan@163.com
08615821120972
Ling Zhan, Doctor
principal investigator · Shanghai 6th People's Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion